These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 16049915)

  • 1. Profile of differentially expressed genes after transfer of chromosome 17 into the breast cancer cell line CAL51.
    Klebig C; Seitz S; Korsching E; Kristiansen G; Gustavus D; Scherneck S; Petersen I
    Genes Chromosomes Cancer; 2005 Nov; 44(3):233-46. PubMed ID: 16049915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic background of different cancer cell lines influences the gene set involved in chromosome 8 mediated breast tumor suppression.
    Seitz S; Korsching E; Weimer J; Jacobsen A; Arnold N; Meindl A; Arnold W; Gustavus D; Klebig C; Petersen I; Scherneck S
    Genes Chromosomes Cancer; 2006 Jun; 45(6):612-27. PubMed ID: 16552773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Identification of the differentially expressed genes between primary breast cancer and paired lymph node metastasis through combining mRNA differential display and gene microarray].
    Feng YM; Gao G; Zhang F; Chen H; Wan YF; Li XQ
    Zhonghua Yi Xue Za Zhi; 2006 Oct; 86(39):2749-55. PubMed ID: 17199993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TOB1 is regulated by EGF-dependent HER2 and EGFR signaling, is highly phosphorylated, and indicates poor prognosis in node-negative breast cancer.
    Helms MW; Kemming D; Contag CH; Pospisil H; Bartkowiak K; Wang A; Chang SY; Buerger H; Brandt BH
    Cancer Res; 2009 Jun; 69(12):5049-56. PubMed ID: 19491269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. cDNA microarray analysis of genes associated with ERBB2 (HER2/neu) overexpression in human mammary luminal epithelial cells.
    Mackay A; Jones C; Dexter T; Silva RL; Bulmer K; Jones A; Simpson P; Harris RA; Jat PS; Neville AM; Reis LF; Lakhani SR; O'Hare MJ
    Oncogene; 2003 May; 22(17):2680-8. PubMed ID: 12730682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene expression signatures in breast cancer distinguish phenotype characteristics, histologic subtypes, and tumor invasiveness.
    Pedraza V; Gomez-Capilla JA; Escaramis G; Gomez C; Torné P; Rivera JM; Gil A; Araque P; Olea N; Estivill X; Fárez-Vidal ME
    Cancer; 2010 Jan; 116(2):486-96. PubMed ID: 20029976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using a xenograft model of human breast cancer metastasis to find genes associated with clinically aggressive disease.
    Kluger HM; Chelouche Lev D; Kluger Y; McCarthy MM; Kiriakova G; Camp RL; Rimm DL; Price JE
    Cancer Res; 2005 Jul; 65(13):5578-87. PubMed ID: 15994930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of caveolin-1 and -2 in cell lines and in human samples of inflammatory breast cancer.
    Van den Eynden GG; Van Laere SJ; Van der Auwera I; Merajver SD; Van Marck EA; van Dam P; Vermeulen PB; Dirix LY; van Golen KL
    Breast Cancer Res Treat; 2006 Feb; 95(3):219-28. PubMed ID: 16244790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of tumorigenicity of breast cancer cells by transfer of human chromosome 17 does not require transferred BRCA1 and p53 genes.
    Theile M; Hartmann S; Scherthan H; Arnold W; Deppert W; Frege R; Glaab F; Haensch W; Scherneck S
    Oncogene; 1995 Feb; 10(3):439-47. PubMed ID: 7845668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene expression profile of mouse prostate tumors reveals dysregulations in major biological processes and identifies potential murine targets for preclinical development of human prostate cancer therapy.
    Haram KM; Peltier HJ; Lu B; Bhasin M; Otu HH; Choy B; Regan M; Libermann TA; Latham GJ; Sanda MG; Arredouani MS
    Prostate; 2008 Oct; 68(14):1517-30. PubMed ID: 18668517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of novel genes that co-cluster with estrogen receptor alpha in breast tumor biopsy specimens, using a large-scale real-time reverse transcription-PCR approach.
    Tozlu S; Girault I; Vacher S; Vendrell J; Andrieu C; Spyratos F; Cohen P; Lidereau R; Bieche I
    Endocr Relat Cancer; 2006 Dec; 13(4):1109-20. PubMed ID: 17158757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA microarray-based transcriptomic profiling of an isogenic cell culture model of breast tumour cell invasion.
    Hughes L; O'Brien SL; Gallagher WM; Mcdonnell S
    Anticancer Res; 2007; 27(3A):1353-9. PubMed ID: 17593630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for a transcriptional signature of breast cancer.
    Feng Y; Li X; Sun B; Wang Y; Zhang L; Pan X; Chen X; Wang X; Wang J; Hao X
    Breast Cancer Res Treat; 2010 Jul; 122(1):65-75. PubMed ID: 19728083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progression-specific genes identified by expression profiling of matched ductal carcinomas in situ and invasive breast tumors, combining laser capture microdissection and oligonucleotide microarray analysis.
    Schuetz CS; Bonin M; Clare SE; Nieselt K; Sotlar K; Walter M; Fehm T; Solomayer E; Riess O; Wallwiener D; Kurek R; Neubauer HJ
    Cancer Res; 2006 May; 66(10):5278-86. PubMed ID: 16707453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic profiling of chromosome 1 in breast cancer: mapping of regions of gains and losses and identification of candidate genes on 1q.
    Orsetti B; Nugoli M; Cervera N; Lasorsa L; Chuchana P; Rougé C; Ursule L; Nguyen C; Bibeau F; Rodriguez C; Theillet C
    Br J Cancer; 2006 Nov; 95(10):1439-47. PubMed ID: 17060936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of the candidate 8p21 tumour suppressor, BNIP3L, in breast and ovarian cancer.
    Lai J; Flanagan J; Phillips WA; Chenevix-Trench G; Arnold J
    Br J Cancer; 2003 Jan; 88(2):270-6. PubMed ID: 12610513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential gene expression profile in breast cancer-derived stromal fibroblasts.
    Singer CF; Gschwantler-Kaulich D; Fink-Retter A; Haas C; Hudelist G; Czerwenka K; Kubista E
    Breast Cancer Res Treat; 2008 Jul; 110(2):273-81. PubMed ID: 17899370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular characterization of breast cancer cell lines by a low-density microarray.
    de Longueville F; Lacroix M; Barbuto AM; Bertholet V; Gallo D; Larsimont D; Marcq L; Zammatteo N; Boffe S; Leclercq G; Remacle J
    Int J Oncol; 2005 Oct; 27(4):881-92. PubMed ID: 16142302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combining serial analysis of gene expression and array technologies to identify genes differentially expressed in breast cancer.
    Nacht M; Ferguson AT; Zhang W; Petroziello JM; Cook BP; Gao YH; Maguire S; Riley D; Coppola G; Landes GM; Madden SL; Sukumar S
    Cancer Res; 1999 Nov; 59(21):5464-70. PubMed ID: 10554019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression profiling of nucleotide metabolism-related genes in human breast cancer cells after treatment with 5-fluorouracil.
    Behera RK; Nayak R
    Cancer Invest; 2009 Jun; 27(5):561-7. PubMed ID: 19219653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.